Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dyadic International, Inc.
Dyadic International and Abengoa Bioenergy New Technologies Settle Litigation and Enter into License Agreement for the Production of Cellulosic Ethanol
May 30th, 2009
Dyadic International, Inc. (Dyadic) (Pink Sheets:DYAI), a global biotechnology company, announced that it has settled all outstanding litigation with Abengoa Bioenergy New Technologies, Inc. (Abengoa Bioenergy) and that the two companies have entered into a non-exclusive license agreement. Under the settlement agreement, in lieu of Abengoa Bioenergy paying an upfront license fee to Dyadic, all outstanding claims between the parties will be dismissed with prejudice. The parties also entered into reciprocal releases covering certain other claims. Additional terms were not disclosed. The non-exclusive license agreement grants Abengoa Bioenergy certain...
Source: Law & Health Weekly (2009-05-30)
|
